# Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator

> **NCT02526290** · NA · COMPLETED · sponsor: **Oculeve, Inc.** · enrollment: 97 (actual)

## Conditions studied

- Dry Eye Syndromes
- Keratoconjunctivitis Sicca

## Interventions

- **DEVICE:** Intranasal Lacrimal Neurostimulator (Oculeve)

## Key facts

- **NCT ID:** NCT02526290
- **Lead sponsor:** Oculeve, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-31
- **Primary completion:** 2016-04-30
- **Final completion:** 2016-04-30
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02526290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02526290, "Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02526290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*